Please login to the form below
relugolix
This page shows the latest relugolix news and features for those working in and with pharma, biotech and healthcare.
Myovant Sciences and Pfizer publish phase 3 results for endometriosis therapy
The data published in The Lancet underscores the value relugolix combination therapy may provide as a potential new treatment option for women with endometriosis-associated pain.”. ... A relugolix combination tablet is currently available in the US as
Latest news
-
FDA approves Myovant’s oral pill Orgovyx for prostate cancer
Orgovyx (relugolix), which will become available for advanced prostate cancer patients in the US, offers a new option that enables at-home administration. ... Secondary endpoints from the study showed that relugolix was better than Lupron at suppressing
-
Myovant preps US filing for relugolix in prostate cancer
Takeda-partnered drug had 97% response rate in advanced prostate cancer. Myovant is locked in a battle with AbbVie for women’s health applications of its GnRH inhibitor relugolix, but a ... The phase 3 HERO trial of Takeda-partnered relugolix has
-
AbbVie files blockbuster hopeful elagolix for uterine fibroids
However, AbbVie is facing some competition in the category from Myovant’s rival drug relugolix, which has just chalked up positive phase 3 trials in uterine fibroids and will set up ... Phil Nadeau – thinks it can and that relugolix will become a $1bn
-
Myovant has second phase 3 trial to back its uterine fibroids drug
Aims to take on AbbVie in new market. Myovant now has two phase 3 trials supporting its relugolix candidate for uterine fibroids, setting up a regulatory filing in the US before ... Myovant is banking on the convenience of once-daily dosing with relugolix
-
Myovant’s fibroids drug clears phase 3 trial, but shares sink
still to report and relugolix filing will likely be several months behind elagolix. ... In Myovant’s favour is that relugolix is also already on the market in Japan, where it is sold by Takeda.
More from news
Approximately 2 fully matching, plus 9 partially matching documents found.
Subscribe to our email news alerts
- Contagious Conversations: Exploring Infectious Disease in the Digital Age
- Austrian State Secretary to speak at FlyPharma Europe 2023
- Further data for AstraZeneca/Daichii Sankyo’s Enhertu for breast cancer requested by NICE
- Gritstone Bio receives $433m BARDA contract for COVID-19 vaccine candidate
- EDX Medical Group develops multi-disease 'point-of-care' rapid tests for cancer, infections and cardiovascular conditions
- ScreenPoint Medical to showcase AI software at European scientific meeting
No results were found
PMHub
Anthill Agency
Digital communications agency empowering clients through their digital transformation journey. Whether through training, delivering solutions or devising digital strategies, we...
Latest intelligence
- The importance of accelerating clinical trial diversity
- Diversity shouldn’t be an afterthought – it’s an investment in the credibility of scientific endeavour...
- Digital Opinion Leaders: The Role of Influencers in Medical Communications
- There are many informed, knowledgeable HCPs who talk about a disease state online, but not all of them are influencers. This paper explores who digital opinion leaders are and how...
- Creating Hope Though Action – World Suicide Prevention Day
- At Mednet Group, we believe that actions speak louder than words. That's why we're getting behind this year's Suicide Prevention Day campaign of 'creating hope through action'....
